- Home
- CDTX vs PCK Comparison
CDTX vs PCK Comparison
Compare CDTX & PCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- PCK
- Stock Information
- Founded
- CDTX 2012
- PCK 2002
- Country
- CDTX United States
- PCK United States
- Employees
- CDTX N/A
- PCK N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- PCK Trusts Except Educational Religious and Charitable
- Sector
- CDTX Health Care
- PCK Finance
- Exchange
- CDTX Nasdaq
- PCK Nasdaq
- Market Cap
- CDTX 229.0M
- PCK 183.5M
- IPO Year
- CDTX 2015
- PCK N/A
- Fundamental
- Price
- CDTX $21.70
- PCK $5.65
- Analyst Decision
- CDTX Strong Buy
- PCK
- Analyst Count
- CDTX 6
- PCK 0
- Target Price
- CDTX $32.20
- PCK N/A
- AVG Volume (30 Days)
- CDTX 127.4K
- PCK 79.7K
- Earning Date
- CDTX 11-07-2024
- PCK 01-01-0001
- Dividend Yield
- CDTX N/A
- PCK 4.58%
- EPS Growth
- CDTX N/A
- PCK N/A
- EPS
- CDTX N/A
- PCK N/A
- Revenue
- CDTX $44,653,000.00
- PCK N/A
- Revenue This Year
- CDTX N/A
- PCK N/A
- Revenue Next Year
- CDTX N/A
- PCK N/A
- P/E Ratio
- CDTX N/A
- PCK N/A
- Revenue Growth
- CDTX 44.48
- PCK N/A
- 52 Week Low
- CDTX $10.00
- PCK $4.85
- 52 Week High
- CDTX $28.42
- PCK $6.33
- Technical
- Relative Strength Index (RSI)
- CDTX 46.63
- PCK 41.29
- Support Level
- CDTX $19.87
- PCK $5.50
- Resistance Level
- CDTX $27.70
- PCK $5.84
- Average True Range (ATR)
- CDTX 2.33
- PCK 0.07
- MACD
- CDTX -0.79
- PCK -0.00
- Stochastic Oscillator
- CDTX 21.40
- PCK 44.12
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About PCK Pimco California Municipal Income Fund II of Beneficial Interest
PIMCO CA Muni Income Fund II is a closed-ended investment company. Its investment objective is to seek to provide current income exempt from federal and California income tax. The company portfolio of investment comprises of different sector investments such as healthcare, education, property, and others.